To answer the question of “what’s next for breast cancer patients?” Susan G. Komen is proud to present the Breast Cancer Breakthrough Series: a virtual, shareable educational series in partnership with industry experts, scientists from academic institutions and patient advocates who will directly speak to recent clinical research findings and new treatments. This series will focus on the new science and technologies that are close to becoming available to patients.
Sign up to be reminded about the next Breast Cancer Breakthroughs episode.
Upcoming Episode
Episode 12: Awareness and Advances in Breast Cancer Brain Metastasis
In partnership with the American Brain Tumor Association, this episode of Breast Cancer Breakthroughs features Dr. Priya Kumthekar and Jose Pablo Leone, who explain the importance of being aware of the signs of brain metastasis and the latest research advances in treating breast cancer brain metastasis.
Past Episodes
Episode 11: Changing the Game with New Hormone Therapies
In this episode of Breast Cancer Breakthroughs, you’ll hear from experts Dr. Sean Fanning and Dr. Priya Rastogi about the next generation of hormone therapies being developed for people with early ER-positive breast cancer.
Read a full synopsis of the episode on the Komen blog.
Find more information from the trial fact sheet
Episode 10: Highlights from the ASCO 2024 Annual Meeting
The 2024 American Society of Clinical Oncology annual meeting, where practice-changing research is announced every year, took place in June. We discussed the top breast cancer takeaways from the meeting with Komen grantees who attended and presented at ASCO, Drs. Tarah Ballinger and Pedram Razavi. In aspects of breast cancer treatment ranging from chemotherapy to antibody drug conjugates to liquid biopsies, they highlighted how research is advancing in a way to personalize treatment – ensuring each patient receives the right treatment at the right time for their unique cancer.
Read a full synopsis of the episode on the Komen blog.
Episode 9: New Frontiers in Early ER-positive Breast Cancer
New frontiers in early ER-positive breast cancer treatments are paving the way for better outcomes for individuals with a high risk for recurrence. In this episode of Breast Cancer Breakthroughs, experts Dr. Sara Tolaney and Dr. Aditya Bardia tell us about new options on the way to decrease risk of recurrence and explain why research for early ER-positive breast cancer is so important.
Read a full synopsis of the episode on the Komen blog.
Find more information from the trial fact sheet
Episode 8: Navigating Breast Cancer Recurrence
Fear of recurrence can be persistent for survivors of early-stage breast cancer, but tools are available to help oncologists and patients understand and manage their risk of recurrence. In this episode of Breast Cancer Breakthroughs, hear how two-time breast cancer survivor Michelle Beck put these tools into practice, and listen as experts Dr. Angela DeMichele and Dr. Ruth O’Regan unravel the mystery of recurrence.
Read a full synopsis of the episode on the Komen blog.
Find more information from the trial fact sheet
Episode 7: Bringing Treatments to Life
Read a full synopsis of the episode on the Komen blog.
Find more information about the Emerald Trial.
Episode 6: Highlights from SABCS 2023
In this episode of Breast Cancer Breakthroughs, hear from Komen researchers about the most exciting wins for patients presented at the 2023 San Antonio Breast Cancer Symposium (SABCS). Advances in research change the way we treat breast cancer in the clinic, and many of these advances are announced at SABCS every year.
Read a full synopsis of the episode on the Komen blog.
Episode 5: Moving the Needle for HER2-Positive Breast Cancer
Since the discovery of HER2, an explosion of HER2-targeted therapies has dramatically improved outcomes for this aggressive type of breast cancer. We’ll hear from Dr. Ian Krop and Dr. Ciara O’Sullivan about how researchers are optimizing these treatments and about new clinical trials that are moving the needle for HER2-positive breast cancer.
Read a full synopsis of the episode on the Komen blog.
Find more information about the HER2CLIMB-05 trial.
Episode 4: Unmet Needs in Triple Negative Breast Cancer
Patients with metastatic triple negative breast cancer (TNBC) desperately need more therapy options. In the next episode of Breast Cancer Breakthroughs, we’ll discuss the latest news and research impacting patients with metastatic TNBC. To discuss these exciting breakthroughs, we’ll hear from Dr. Lisa Carey, a world-renowned TNBC expert and Komen Scientific Advisory Board member, and Dr. Tiffany Traina, an oncologist researching an exciting new antibody drug conjugate for TNBC.
Read a full synopsis of the episode on the Komen blog.
Find more information about the TROPION-Breast02 trial.
Episode 3: Highlights from the 2023 ASCO Annual Meeting
The latest advances in breast cancer research were recently announced at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting. We’ll highlight the most exciting results from the meeting, covering topics such as CDK4/6 inhibitors, a new antibody drug conjugate and personalized medicine. Hear from experts Erika Hamilton, M.D., and Sherene Loi, M.D., Ph.D., about how these breakthroughs from ASCO will impact patient care.
Read a full synopsis of the episode on the Komen blog.
Episode 2: Demystifying Treatment De-Escalation
Doctors treat breast cancer through a combination of surgery, radiation and pharmaceuticals, but are these grueling regimens necessary for all patients? Learn from experts Dr. Antonio Wolff and Dr. Daniel Stover about the latest breakthroughs in breast cancer research that are pinpointing which patients can safely avoid some treatments to effectively treat their cancer.
Read a full synopsis of the episode on the Komen Blog.
Episode 1: Highlight from the San Antonio Breast Cancer Symposium
In this first installment of the Breast Cancer Breakthroughs series, Victoria Smart, Senior Vice President of Mission at Komen, joins Thelma Brown, a two-time breast cancer survivor and Komen Advocate in Science, and Dr. Sara Tolaney, Komen Scholar and oncologist, to discuss some of the exciting developments that came out of the 2022 San Antonio Breast Cancer Symposium (SABCS).
Read a full synopsis of the episode on the Komen Blog.
About Breast Cancer Breakthroughs
Advances in research, technologies and clinical trial results are being announced at a record pace, but what does it mean for patients? Patients and caregivers need to be hopeful and informed about the developing breast cancer treatments of tomorrow. This series will shine a light on the exciting new treatments and technologies that are on the horizon for patients.
Sponsors
Thank you to the following partners for their support of the Breast Cancer Breakthroughs Series
Sign up to be reminded about the next Breast Cancer Breakthroughs episode.
You can help discover cures to breast cancer, faster.
Your breast cancer information is as unique as you are. When combined with other ShareForCures members, you provide scientists with a more diverse set of data to make new discoveries, faster.